SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea
· Delayed Price · Currency is KRW 823.00
-37.00 (-4.30%)
At close: Mar 9, 2026
SCM Lifescience Company Description
SCM Lifescience Co., Ltd. operates as a stem cell therapy company in South Korea.
It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief.
The company was founded in 2014 and is headquartered in Incheon, South Korea.
SCM Lifescience Co., Ltd.
| Country | South Korea |
| Founded | 2014 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Byeong-gwan Son |
Contact Details
Address: 7-7, Gaetbeol-ro 145beon-gil Incheon, 21999 South Korea | |
| Phone | 82 3 2881 3600 |
| Website | scmlifescience.co.kr |
Stock Details
| Ticker Symbol | 298060 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Byeong-gwan Son | Chief Executive Officer |
| Sukwoo Jeffrey Oh | Chief Operating Officer |